טרימבו 100/6/12.5 - Trimbow 100/6/12.5
× ×ª×× × ×ª×¨×פ×
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ש×××¤× - INHALATION |
| צ×רת ××× ×× | PRESSURISED SOLUTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Trimbow is indicated for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist. |
| ×ת××ת ××× ×× | [24/05/2021 Posology and method of administration] |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×ר×××× 100/6/12.5 ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | CHIESI FARMACEUTICI S.P.A, ITALY |
| ×©× ××¢× ×ר×ש×× | KAMADA LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 5/2019. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | {{{ת×ר×× ×¢××××}}} |
השינוי האחרון נעשה בֹ־13 במאי 2025 ב־06:53